ℹ️
🇬🇧
Search
Search for publications relevant for "Bruton´s"
Bruton´s
Publication
Class
Person
Publication
Programmes
publication
Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia
2023 |
First Faculty of Medicine
publication
Long-term Treatment of Patients with X-linked Hypogammablobulinaemia (Bruton ´s disease) - 3 Case Studies
2003 |
First Faculty of Medicine
publication
X-linked Hypogammaglobulinaemia (Bruton´s Disease) - Three Case Studies and Molecular Genetic Studies in Their Families
2004 |
First Faculty of Medicine
publication
X-linked Hypogammaglobulinaemia (Bruton´s Disease) - Three Case Studies and Molecular Genetic Studies in Their Families
2004 |
Central Library of Charles University, Faculty of Medicine in Hradec Králové
publication
Long-term Treatment of Patients with X-linked Hypogammablobulinaemia (Bruton ´s disease) - 3 Case Studies
2003 |
Faculty of Medicine in Hradec Králové
publication
Brutonova agamaglobulinemie - kazuistika
2006 |
Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia
2008 |
Second Faculty of Medicine
publication
Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Research Report University Hospital for clinical evaluation of PCI-32765MCL3002
Publication without faculty affiliation
publication
Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Cytokiny v supernatantech lymfocytárních kultur pacientů trpících X vázanou hypogamaglobulinemií (morbus Bruton)
Publication without faculty affiliation
publication
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Targeting phosphatidylinositol 3 kinase-beta and -delta for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma
2020 |
First Faculty of Medicine
publication
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia
2022 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: PCYC-1115-CA
Publication without faculty affiliation
publication
Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PCYC-1130-CA
Publication without faculty affiliation
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Contiguous x-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes
2007 |
Second Faculty of Medicine
publication
Use of ibrutinib as "bridging" for allogeneic hematopoietic stem cell transplantation from haploidentic donor and subsequent therapy of residual disease after transplantation in a patient with highly adverse mantle cell lymphoma
2019 |
First Faculty of Medicine
publication
Fixed duration therapy in patients with chronic lymphocytic leukemia
2023 |
Publication without faculty affiliation
publication
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study
2016 |
First Faculty of Medicine
publication
Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia
2022 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Dendritic cells in immunopathology
Publication without faculty affiliation
publication
New possibilities and perspectives of immunoglobulin therapy
2016 |
Second Faculty of Medicine
publication
Primární a sekundární imunodeficience, přehled a klasifikace
Publication without faculty affiliation
publication
Efekt léčby ibrutinibem u relapsu CLL po alogenní transplantaci krvetvorných buněk
2017 |
First Faculty of Medicine
publication
Acalabrutinib
2021 |
Third Faculty of Medicine
publication
Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future
2015 |
First Faculty of Medicine
publication
Modern approach to the treatment of chronic lymphocytic leukemia
2023 |
Faculty of Medicine in Hradec Králové
publication
The terapeutic Options for ""Slow- go"" Patients with Chronic Lymphocytic Leukemia
2015 |
Faculty of Medicine in Hradec Králové